Literature DB >> 14741251

Rational design and synthesis of selective BACE-1 inhibitors.

Stephen F Brady1, Satendra Singh, Ming Chih Crouthamel, M Katharine Holloway, Craig A Coburn, Victor M Garsky, Michael Bogusky, Michael W Pennington, Joseph P Vacca, Daria Hazuda, Ming-Tain Lai.   

Abstract

An effective approach for enhancing the selectivity of beta-site amyloid precursor protein cleaving enzyme (BACE 1) inhibitors is developed based on the unique features of the S1' pocket of the enzyme. A series of low molecular weight (<600) compounds were synthesized with different moieties at the P1' position. The selectivity of BACE 1 inhibitors versus cathepsin D and renin was enhanced 120-fold by replacing the hydrophobic propyl group with a hydrophilic propionic acid group.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741251     DOI: 10.1016/j.bmcl.2003.11.061

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination.

Authors:  Xiaoyang Luo; Marguerite Prior; Wanxia He; Xiangyou Hu; Xiaoying Tang; Weizhen Shen; Satya Yadav; Sumiko Kiryu-Seo; Robert Miller; Bruce D Trapp; Riqiang Yan
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

2.  Design and characterization of a new cell-permeant inhibitor of the beta-secretase BACE1.

Authors:  Solveig Lefranc-Jullien; Vincent Lisowski; Jean-François Hernandez; Jean Martinez; Frédéric Checler
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

3.  Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves.

Authors:  Xiangyou Hu; Wanxia He; Claudiu Diaconu; Xiaoying Tang; Grahame J Kidd; Wendy B Macklin; Bruce D Trapp; Riqiang Yan
Journal:  FASEB J       Date:  2008-04-15       Impact factor: 5.191

Review 4.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Heather L Osswald
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

5.  From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer's disease.

Authors:  Jutamas Jiaranaikulwanitch; Piyarat Govitrapong; Valery V Fokin; Opa Vajragupta
Journal:  Molecules       Date:  2012-07-10       Impact factor: 4.411

Review 6.  New directions for protease inhibitors directed drug discovery.

Authors:  Yoshio Hamada; Yoshiaki Kiso
Journal:  Biopolymers       Date:  2016-11-04       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.